Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type b combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age

Chang Gung Medical Journal

Volumn 26, Issue 5, 2003, Pages 315-322

  Lin, Tzou Yien ^a   Wang, Ying Hsiang ^b   Chang, Luan Yin ^b   Chiu, Cheng Hsun ^b   Huang, Yhu Chering ^b   Tang, Haiwen ^b   Bock, Hans L ^b  

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^b NONE

Author keywords

And acellular pertussis; Diphtheria; Haemophilus influenzae type b; Immunogenicity; Inactivated poliovirus vaccine; Reactogenicity; Tetanus

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INFANRIX IPV;

ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOGENICITY; INFANT; INJECTION PAIN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SIDE EFFECT; TAIWAN; VACCINATION;

ANTIBODIES, BACTERIAL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INFANT; POLIOVIRUS VACCINE, INACTIVATED; POLYSACCHARIDES, BACTERIAL; TAIWAN; VACCINATION; VACCINES, COMBINED;

EID: 0043235634     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Decker MD, Edwards KM. Combination vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia: WB Saunders, 1999:308-30.
2. Hadler SC. Cost benefit of combining antigens. Biologicals 1994;22:415-8.
3. Knutsson N, Trollfors B, Taranger J, Bergfors E, Sundh V, Lagergard T, Ostergaard E, Cicirello H, Kayhty H. Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine. Vaccine 2001;19:4396-403.
4. Yeh SH, Ward JI, Partridge S, Marcy SM, Lee H, Jing J, Curry ES, Howe BJ. Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants. Pediatr Infect Dis J 2001;20:973-80.
5. Cherian T, Thomas N, Raghupathy P, Durot I, Dutta A. Safety and immunogenicity of Haemophilus influenza type B vaccine given in combination with DTwP at 6, 10 and 14 weeks of age. Indian Pediatrics 2002;39:427-36.
6. Cody CL, Baraff LJ, Cherry JD, Marcy SM, Manclark CR. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981;68:650-60.
7. Kimura M, Kuno-Sakai H. Current epidemiology of pertussis in Japan. Pediatr Infect Dis J 1990;9:705-9.
8. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996;334:349-55.
9. Wang CH and Lin TY. Invasive Haemophilus influenzae diseases and purulent meningitis in Taiwan. J Formos Med Assoc 1996;95:599-604.
10. Bisgard KM, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M. Haemophilus influenzae invasive disease in the United States, 1994-1995: Near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis 1998;4:229-37.
11. Plotkin S. Developed countries should use inactivated polio vaccine for the prevention of poliomyelitis. Rev Med Virol 1997;7:75-81.
12. Committee on Infectious Diseases. Prevention of poliomyelitis: recommendations for use of only inactivated poliovirus vaccine for routine immunization. Pediatrics 1999;104:1404-6.
13. Eskola J, Olander RM, Hovi T, Litmanen L, Peltola S, Kayhty H. Randomized trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. Lancet 1996;348:1688-92.
14. Lagos R, Kotloff K, Hoffenbach A, San Martin O, Abrego P, Ureta AM, Pines E, Blondeau C, Bailleux F, Levine MM. Clinical acceptability and immunogenicity of pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four-, and six-month-old children infants. Pediatr Infect Dis J 1998;17:294-304.
15. Edwards KM, Decker MD. Combination vaccines consisting of acellular pertussis vaccines. Pediatr Infect Dis J 1997;16:S97-102.
16. Halperin SA, Barreto L, Eastwood BJ, Medd L, Guasparini R, Mills E. Safety and immunogenicity of an acellular pertussis diphtheria tetanus vaccine given as a single injection with Haemophilus influenzae type b conjugate vaccine. Vaccine 1997;15:295-300.
17. Lee CY, Thipphawong J, Huang LM, Lee PI, Chiu HH, Lin W, Debois H, Harrison D, Xie F, Barreto L. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Hemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants. Pediatrics 1999;103:25-30.
18. Greenberg DP, Wong VK, Partridge S, Chang SJ, Chiu CY, Ward JI. Evaluation of a new combination vaccine that incorporates diphtheria-tetanus-acellular pertussis, hepatitis B and Hemophilus influenzae type b conjugate vaccines (abstract G70). In: Programs and Abstracts of the 35th Interscience Conference on Antimicrobials and Chemotherapy. Washington, DC. American Society for Microbiology; 1995:170.
19. Poolman J, Kanfhold A, De Grave D, Goldblatt D. Clinical relevance of lower Hib response in DTaP-based combination vaccines. Vaccine 2001;19:2280-5.
20. Schmitt HJ, von Kries R, Hassenpflug B, Hermann M, Siedler A, Niessing W, Clemens R, Weil J. Haemophilus influenzae type b disease, impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis(-inactivated poliovirus)/H. influenzae type b combination vaccines. Pediatr Infect Dis J 2001;20:767-74.